|1.||Kurata, Yasushi: 2 articles (05/2005 - 06/2002)|
|2.||Tabata, Yuji: 2 articles (05/2005 - 06/2002)|
|3.||Driggers, Paul: 1 article (10/2010)|
|4.||Segars, James: 1 article (10/2010)|
|5.||Malik, Minnie: 1 article (10/2010)|
|6.||Davis, Joseph: 1 article (10/2010)|
|7.||Chappel, Scott: 1 article (10/2010)|
|8.||Catherino, William H: 1 article (10/2010)|
|9.||Hoshiko, Shigeru: 1 article (05/2005)|
|10.||Okonogi, Tsuneo: 1 article (05/2005)|
|1.||Leiomyoma (Uterine Fibroids)
10/01/2010 - "The goal of these studies was to determine the progesterone receptor (PR) specificity and activation, endometrial response, and impact on leiomyoma cell proliferation and extracellular matrix (ECM) production of the novel non-steroidal selective progesterone receptor modulators (SPRMs) CP8863 and CP8947. "
06/21/2002 - "The incidence of adenomyosis was significantly lower in the groups of mice treated with CP8816 and CP8863 than in the respective control groups. "
06/21/2002 - "The possibility of therapeutic application of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 for preventing the development of uterine adenomyosis was investigated in mice. "
06/21/2002 - "Priming effects of novel nonsteroidal progesterone receptor modulators CP8816 and CP8863 on the development of adenomyosis in the mouse uterus."
|1.||Progesterone Receptors (Progesterone Receptor)